Facts Views and Vision in ObGyn最新文献

英文中文

The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation 欧洲首个使用新型手术机器人Hugo™RAS的妇科手术。1例BRCA-1突变患者行全子宫切除和输卵管卵巢切除术

IF 2 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2022-03-01 DOI: 10.52054/FVVO.14.1.014

G. Monterossi, L. Pedone Anchora, S. Gueli Alletti, A. Fagotti, F. Fanfani, G. Scambia

Background The benefits of minimally invasive surgery are well known in gynaecology. Robotic-assisted surgery has gained widespread acceptance within the surgical community and seems to be the most rapidly developing sector of minimally invasive surgery. Objectives This video shows the salient steps of total hysterectomy with new robotic technology, Hugo™ RAS. The objectives were to introduce and demonstrate the feasibility, efficacy, and safety of this new advanced device. Materials and Methods A sixty-two years-old woman affected by BRCA-1 mutation underwent the first European gynaecological surgical procedure using the new surgical robot Hugo™ RAS in the Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Main outcome measures Docking and operative times. Results The docking time was 6 minutes and the total operative time was 58 minutes. There were no system errors and faults in the robotic arms. The surgeon found no friction or rasping in the arms. The estimated blood loss was 30 mL. No intraoperative complications were recorded. Conclusion Gynaecological surgery with Hugo™ RAS seems feasible, safe and effective as shown by initial experiences in urological surgery. A larger case series would confirm the current experience and determine whether this technology could offer any additional benefit.

背景微创手术在妇科的好处是众所周知的。机器人辅助手术在外科界得到了广泛的接受，似乎是微创手术中发展最快的领域。目的:本视频展示了采用新型机器人技术Hugo™RAS进行全子宫切除术的主要步骤。目的是介绍和证明这种新的先进设备的可行性、有效性和安全性。材料和方法一名患有BRCA-1突变的62岁女性在意大利罗马的Fondazione Policlinico Universitario A. Gemelli IRCCS妇科肿瘤科使用新型手术机器人Hugo™RAS接受了首次欧洲妇科手术。主要观察指标:对接和手术时间。结果对接时间6分钟，总手术时间58分钟。机械臂上没有系统错误和故障。外科医生没有发现手臂上的摩擦或摩擦。估计失血量为30ml，无术中并发症记录。结论从泌尿外科的初步经验来看，Hugo™RAS在妇科手术中是可行、安全、有效的。一个更大的案例系列将证实目前的经验，并确定这项技术是否可以提供任何额外的好处。

{"title":"The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation","authors":"G. Monterossi, L. Pedone Anchora, S. Gueli Alletti, A. Fagotti, F. Fanfani, G. Scambia","doi":"10.52054/FVVO.14.1.014","DOIUrl":"https://doi.org/10.52054/FVVO.14.1.014","url":null,"abstract":"Background The benefits of minimally invasive surgery are well known in gynaecology. Robotic-assisted surgery has gained widespread acceptance within the surgical community and seems to be the most rapidly developing sector of minimally invasive surgery. Objectives This video shows the salient steps of total hysterectomy with new robotic technology, Hugo™ RAS. The objectives were to introduce and demonstrate the feasibility, efficacy, and safety of this new advanced device. Materials and Methods A sixty-two years-old woman affected by BRCA-1 mutation underwent the first European gynaecological surgical procedure using the new surgical robot Hugo™ RAS in the Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Main outcome measures Docking and operative times. Results The docking time was 6 minutes and the total operative time was 58 minutes. There were no system errors and faults in the robotic arms. The surgeon found no friction or rasping in the arms. The estimated blood loss was 30 mL. No intraoperative complications were recorded. Conclusion Gynaecological surgery with Hugo™ RAS seems feasible, safe and effective as shown by initial experiences in urological surgery. A larger case series would confirm the current experience and determine whether this technology could offer any additional benefit.","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":"14 1","pages":"91 - 94"},"PeriodicalIF":2.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47628477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 13

Intrauterine Bigatti Shaver (IBS®) successful placental remnants removal, after caesarean section for a cervical pregnancy with placenta accreta 宫内Bigatti剃须刀(IBS®)成功清除胎盘残余，剖腹产后宫颈妊娠伴有胎盘增生

IF 2 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2022-03-01 DOI: 10.52054/FVVO.14.1.010

J. Shi, Y. Zhang, S. Zhang, X. Yin, D. An, J. Zhang, J. Cheng, Y. Wang, A. Zhao, W. Di, R. Campo, G. Bigatti

Placenta accreta located in a caesarean section scar is difficult to remove. The Intrauterine Bigatti Shaver (IBS®) has already been proven to be effective in placental remnant removal. Our case report highlights that the IBS® is also a safe method to remove placental remnants attached to a previous caesarean section scar performed for a cervical pregnancy and associated with placenta accreta.

植入胎盘位于剖腹产疤痕中，很难去除。宫内Bigatti剃须刀（IBS®）已被证明能有效去除胎盘残留物。我们的病例报告强调，IBS®也是一种安全的方法，可以去除附着在先前宫颈妊娠剖腹产疤痕上的胎盘残留物，并与胎盘植入有关。

引用次数: 0

Total surgical time in laparoscopic supracervical hysterectomy with laparoscopic in-bag-morcellation compared to laparoscopic supracervical hysterectomy with uncontained morcellation 腹腔镜宫颈上子宫切除术的总手术时间与腹腔镜宫颈上子宫切除术的总手术时间比较

IF 2 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2022-03-01 DOI: 10.52054/FVVO.14.1.006

H. Krentel, G. Tchartchian, L. A. Torres de la Roche, R. D. De Wilde

Background A possible solution to the problem of cell dissemination through laparoscopic uncontained morcellation during laparoscopic supracervical hysterectomy (LASH) is the use of laparoscopic in-bag morcellation. One criticism regarding the use of in-bag morcellation is the additional surgical time associated with this procedure. Objectives In this retrospective study we compared the total surgical time in LASH with laparoscopic in-bag morcellation (107 cases from 2016-2018) and LASH with uncontained morcellation (47 cases from 2015-2017). Materials and Methods All surgeries were performed in the same department of minimally invasive gynaecological surgery by a total of three experienced surgeons for the indication of bleeding disorder and / or dysmenorrhea. Main outcome measures We measured and compared total surgical time, surgical outcome, blood loss and complications in LASH with in-bag morcellation and with uncontained morcellation. Results Total surgical time in both procedures do not show a significant difference. Considering the learning curve in laparoscopic bag use, the total surgical time in LASH with laparoscopic in-bag morcellation is shorter than total surgical time in LASH with uncontained morcellation. Laparoscopic in-bag morcellation consumes time for bag use and handling, but saves time as it eliminates the need for meticulous sampling of lost tissue fragments and the complex lavage of the peritoneal cavity after morcellation. There is no difference between both groups in terms of blood loss, complications and surgical results. Conclusion/What is new? We conclude that LASH with in-bag morcellation is not related to additional surgical time when compared to LASH with uncontained morcellation.

背景腹腔镜宫颈上子宫切除术(LASH)中腹腔镜无包膜分碎术可能解决细胞播散的问题，即腹腔镜袋内分碎术。关于使用袋内粉碎术的一个批评是与该手术相关的额外手术时间。目的在本回顾性研究中，我们比较了2016-2018年腹腔镜袋内分碎术(107例)和2015-2017年非包内分碎术(47例)的总手术时间。材料与方法所有手术均在同一妇科微创外科由3名经验丰富的外科医生以出血性疾病和/或痛经为指征进行。我们测量并比较了袋内分块术和非包膜分块术的总手术时间、手术结果、出血量和并发症。结果两种手术方式的总手术时间差异无统计学意义。考虑到腹腔镜袋使用的学习曲线，腹腔镜袋内分碎术的总手术时间要短于腹腔镜袋内分碎术的总手术时间。腹腔镜袋内分碎术虽然使用袋子和搬运时间较长，但由于不需要对丢失的组织碎片进行细致的取样和分碎后腹腔的复杂灌洗，节省了时间。两组在出血量、并发症和手术结果方面没有差异。结论/什么是新的?我们的结论是，与袋内粉碎术相比，袋内粉碎术与额外的手术时间无关。

{"title":"Total surgical time in laparoscopic supracervical hysterectomy with laparoscopic in-bag-morcellation compared to laparoscopic supracervical hysterectomy with uncontained morcellation","authors":"H. Krentel, G. Tchartchian, L. A. Torres de la Roche, R. D. De Wilde","doi":"10.52054/FVVO.14.1.006","DOIUrl":"https://doi.org/10.52054/FVVO.14.1.006","url":null,"abstract":"Background A possible solution to the problem of cell dissemination through laparoscopic uncontained morcellation during laparoscopic supracervical hysterectomy (LASH) is the use of laparoscopic in-bag morcellation. One criticism regarding the use of in-bag morcellation is the additional surgical time associated with this procedure. Objectives In this retrospective study we compared the total surgical time in LASH with laparoscopic in-bag morcellation (107 cases from 2016-2018) and LASH with uncontained morcellation (47 cases from 2015-2017). Materials and Methods All surgeries were performed in the same department of minimally invasive gynaecological surgery by a total of three experienced surgeons for the indication of bleeding disorder and / or dysmenorrhea. Main outcome measures We measured and compared total surgical time, surgical outcome, blood loss and complications in LASH with in-bag morcellation and with uncontained morcellation. Results Total surgical time in both procedures do not show a significant difference. Considering the learning curve in laparoscopic bag use, the total surgical time in LASH with laparoscopic in-bag morcellation is shorter than total surgical time in LASH with uncontained morcellation. Laparoscopic in-bag morcellation consumes time for bag use and handling, but saves time as it eliminates the need for meticulous sampling of lost tissue fragments and the complex lavage of the peritoneal cavity after morcellation. There is no difference between both groups in terms of blood loss, complications and surgical results. Conclusion/What is new? We conclude that LASH with in-bag morcellation is not related to additional surgical time when compared to LASH with uncontained morcellation.","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":"14 1","pages":"59 - 68"},"PeriodicalIF":2.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41797327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Clomiphene citrate stimulated cycles – additional gonadotrophin stimulation increases endometrium thickness without increasing implantation rate 克罗米芬柠檬酸盐刺激周期-额外的促性腺激素刺激增加子宫内膜厚度而不增加植入率

IF 2 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2022-03-01 DOI: 10.52054/FVVO.14.1.013

I. Magaton, A. Helmer, M. Roumet, P. Stute, M. von Wolff

It is known that Clomiphene citrate (CC) reduces endometrial thickness, but it is unknown if additional gonadotrophin stimulation increases endometrial thickness and if this has an effect on implantation rate in in vitro fertilization (IVF). The retrospective study included 263 minimal stimulation IVF-cycles stimulated with 25 mg CC per day (CC- IVF), and 161 IVF-cycles stimulated with CC plus 75IU hMG (human Menopausal Gonadotrophin) per day (CC/ hMG-IVF). Endometrial and oestradiol (E2) measurements were analysed between day -4 and 0 (0 = day of oocyte retrieval) and the association of endometrial thickness and treatment on implantation rates were studied after multiple adjustments. It was shown that on day 0, endometrium was significantly thicker in CC/hMG-IVF versus CC-IVF cycles (9.81 ±2.68 versus 9.06 ±2.54 mm, p = 0.005). However, increased endometrial thickness did not have an effect on implantation and live birth rates. In conclusion, gonadotrophins should not be added to low dose CC treated IVF cycles just to increase endometrial thickness as increased endometrial thickness does not increase implantation rate.

众所周知，克罗米芬柠檬酸盐（CC）可减少子宫内膜厚度，但尚不清楚额外的促性腺激素刺激是否会增加子宫内膜厚度以及这是否会对体外受精（IVF）的植入率产生影响。这项回顾性研究包括263个每天用25 mg CC刺激的最小刺激IVF周期（CC-IVF），以及161个每天用CC加75IU hMG（人类更年期促性腺激素）刺激的IVF周期。分析第-4天至第0天（0=取卵日）的子宫内膜和雌二醇（E2）测量值，并在多次调整后研究子宫内膜厚度和治疗对植入率的影响。结果表明，在第0天，CC/hMG IVF周期的子宫内膜明显增厚（9.81±2.68对9.06±2.54mm，p=0.005）。然而，子宫内膜厚度的增加对植入率和活产率没有影响。总之，促性腺激素不应该仅仅为了增加子宫内膜厚度而添加到低剂量CC治疗的IVF周期中，因为增加的子宫内膜厚度不会增加植入率。

{"title":"Clomiphene citrate stimulated cycles – additional gonadotrophin stimulation increases endometrium thickness without increasing implantation rate","authors":"I. Magaton, A. Helmer, M. Roumet, P. Stute, M. von Wolff","doi":"10.52054/FVVO.14.1.013","DOIUrl":"https://doi.org/10.52054/FVVO.14.1.013","url":null,"abstract":"It is known that Clomiphene citrate (CC) reduces endometrial thickness, but it is unknown if additional gonadotrophin stimulation increases endometrial thickness and if this has an effect on implantation rate in in vitro fertilization (IVF). The retrospective study included 263 minimal stimulation IVF-cycles stimulated with 25 mg CC per day (CC- IVF), and 161 IVF-cycles stimulated with CC plus 75IU hMG (human Menopausal Gonadotrophin) per day (CC/ hMG-IVF). Endometrial and oestradiol (E2) measurements were analysed between day -4 and 0 (0 = day of oocyte retrieval) and the association of endometrial thickness and treatment on implantation rates were studied after multiple adjustments. It was shown that on day 0, endometrium was significantly thicker in CC/hMG-IVF versus CC-IVF cycles (9.81 ±2.68 versus 9.06 ±2.54 mm, p = 0.005). However, increased endometrial thickness did not have an effect on implantation and live birth rates. In conclusion, gonadotrophins should not be added to low dose CC treated IVF cycles just to increase endometrial thickness as increased endometrial thickness does not increase implantation rate.","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":"14 1","pages":"77 - 81"},"PeriodicalIF":2.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47351910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impact of the COVID-19 pandemic on surgery for severe endometriosis in the UK: a national database study COVID-19大流行对英国严重子宫内膜异位症手术的影响:一项国家数据库研究

IF 2 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2021-09-25 DOI: 10.22541/au.163256909.93155355/v1

J. Lewin, E. Sarıdoğan, D. Byrne, T. J. Clark, A. Vashisht

Background The COVID-19 pandemic has had a significant effect on healthcare services, particularly affecting patients who suffer from chronic conditions. However, the pandemic’s effect on endometriosis surgery is not yet known. Objectives To determine the impact of the COVID-19 pandemic on surgery for severe endometriosis in the UK at a national, regional and centre-level. Materials and Methods The British Society for Gynaecological Endoscopy (BSGE) collects data nationally on all operations for severe endometriosis which involve dissection of the pararectal space. Annual audits of this database were obtained from the BSGE. Publicly available data on COVID-19 cases and population were obtained from the UK Office for National Statistics. Main outcome measures Numbers of annual BSGE-registered endometriosis operations. Results A total of 8204 operations were performed. The number of operations decreased by 49.4% between 2019 and 2020 and then increased in 2021, but remained 10.5% below average pre-pandemic levels, indicating at least 980 missed operations between 2019-2020. Median operations per centre decreased by 51.0% in 2020 (IQR 29.4% – 75.0%) and increased in 2021 but remained 33% below pre-pandemic levels. There was no change in the type of surgery performed. All 11 administrative regions of Great Britain had reduced numbers of operations in 2020 compared with the average for 2017-2019, with a median 44.2% decrease (range 13.3% - 67.5%). Regional reduction in operations was correlated with COVID-19 infection rates (r=0.54, 95% CI of r 0.022 – 1.00, p=0.043). Conclusion The number of operations performed annually in the UK for severe endometriosis fell dramatically during the COVID-19 pandemic and is yet to normalise. What's new? This study shows the dramatic effect that the COVID-19 pandemic has had on UK services for endometriosis surgery, which may continue to affect patients and clinicians for a considerable time to come.

COVID-19大流行对医疗保健服务产生了重大影响，特别是对患有慢性病的患者。然而，大流行对子宫内膜异位症手术的影响尚不清楚。目的从国家、地区和中心层面确定COVID-19大流行对英国严重子宫内膜异位症手术的影响。材料和方法英国妇科内镜学会(BSGE)收集了全国范围内所有涉及直肠旁间隙剥离的严重子宫内膜异位症手术的数据。该数据库的年度审计是从BSGE获得的。有关COVID-19病例和人口的公开数据来自英国国家统计局。主要观察指标每年bsge登记的子宫内膜异位症手术数。结果共手术8204例。2019年至2020年期间，手术数量减少了49.4%，然后在2021年有所增加，但仍比大流行前的平均水平低10.5%，这表明2019年至2020年期间至少有980例手术未进行。2020年，每个中心的业务中位数下降了51.0% (IQR为29.4% - 75.0%)，2021年有所增加，但仍比大流行前的水平低33%。手术类型没有变化。与2017-2019年的平均水平相比，英国所有11个行政区在2020年的运营数量都有所减少，中位数下降44.2%(范围为13.3% - 67.5%)。区域手术减少与COVID-19感染率相关(r=0.54, 95% CI为r 0.022 ~ 1.00, p=0.043)。结论2019冠状病毒病大流行期间，英国严重子宫内膜异位症的年手术数量急剧下降，尚未恢复正常。有什么新鲜事吗?这项研究表明，COVID-19大流行对英国子宫内膜异位症手术服务产生了巨大影响，这可能会在未来相当长一段时间内继续影响患者和临床医生。

{"title":"Impact of the COVID-19 pandemic on surgery for severe endometriosis in the UK: a national database study","authors":"J. Lewin, E. Sarıdoğan, D. Byrne, T. J. Clark, A. Vashisht","doi":"10.22541/au.163256909.93155355/v1","DOIUrl":"https://doi.org/10.22541/au.163256909.93155355/v1","url":null,"abstract":"Background The COVID-19 pandemic has had a significant effect on healthcare services, particularly affecting patients who suffer from chronic conditions. However, the pandemic’s effect on endometriosis surgery is not yet known. Objectives To determine the impact of the COVID-19 pandemic on surgery for severe endometriosis in the UK at a national, regional and centre-level. Materials and Methods The British Society for Gynaecological Endoscopy (BSGE) collects data nationally on all operations for severe endometriosis which involve dissection of the pararectal space. Annual audits of this database were obtained from the BSGE. Publicly available data on COVID-19 cases and population were obtained from the UK Office for National Statistics. Main outcome measures Numbers of annual BSGE-registered endometriosis operations. Results A total of 8204 operations were performed. The number of operations decreased by 49.4% between 2019 and 2020 and then increased in 2021, but remained 10.5% below average pre-pandemic levels, indicating at least 980 missed operations between 2019-2020. Median operations per centre decreased by 51.0% in 2020 (IQR 29.4% – 75.0%) and increased in 2021 but remained 33% below pre-pandemic levels. There was no change in the type of surgery performed. All 11 administrative regions of Great Britain had reduced numbers of operations in 2020 compared with the average for 2017-2019, with a median 44.2% decrease (range 13.3% - 67.5%). Regional reduction in operations was correlated with COVID-19 infection rates (r=0.54, 95% CI of r 0.022 – 1.00, p=0.043). Conclusion The number of operations performed annually in the UK for severe endometriosis fell dramatically during the COVID-19 pandemic and is yet to normalise. What's new? This study shows the dramatic effect that the COVID-19 pandemic has had on UK services for endometriosis surgery, which may continue to affect patients and clinicians for a considerable time to come.","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":"14 1","pages":"309 - 315"},"PeriodicalIF":2.0,"publicationDate":"2021-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44777428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

New approach for T-shaped uterus: Metroplasty with resection of lateral fibromuscular tissue using a 15 Fr miniresectoscope. A step-by-step technique. t型子宫的新方法:15fr微型切除术镜下子宫成形术切除外侧纤维肌肉组织。一步一步的技巧。

IF 2 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2021-03-31 DOI: 10.52054/FVVO.13.003

U. Catena, R. Campo, G. Bolomini, M. Moruzzi, V. Verdecchia, F. Nardelli, I. Romito, F. Camolo, V. L. Manna, M. Ianieri, G. Scambia, A. Testa

T-shaped uterus is a congenital uterine malformation (CUM), only recently defined by the ESGE ESHRE classification as Class U1a. The uterus is characterised by a narrow uterine cavity due to thickened lateral walls with a correlation 2/3 uterine corpus and 1/3 cervix (Grimbizis et al, 2013). Although the significance of this dysmorphic malformation on reproductive performance has been questioned, recent studies reported significant improvement of life birth rates after surgical correction in patients with failed in-vitro fertilisation (IVF) or recurrent miscarriage (Ferro et al, 2018; Di Spiezio Sardo et al, 2020; Alonso Pacheco et al. 2019). The classical surgical technique to treat a T-shaped uterus is by performing a sidewall incision with the micro scissor or bipolar needle, resulting in a triangular cavity. In this video article, we describe a new surgical technique with a step-by-step method combining three-dimensional ultrasound (3D-US) and hysteroscopic metroplasty in an office setting, using a 15 Fr office resectoscope (Karl Storz, Tuttlingen, Germany), to treat a T-shaped uterus by resecting the lateral fibromuscular tissue of the uterine walls. No complications occurred and the postoperative hysteroscopy showed a triangular and symmetrical uterine cavity without any adhesions.

T型子宫是一种先天性子宫畸形（CUM），最近才被ESGE ESHRE分类为U1a级。子宫的特征是侧壁增厚导致子宫腔狭窄，相关的子宫体为2/3，宫颈为1/3（Grimbizis等人，2013）。尽管这种畸形对生殖能力的影响受到质疑，但最近的研究报告称，体外受精失败或反复流产的患者在手术矫正后，生活出生率显著提高（Ferro等人，2018；Di Spiezio Sardo等人，2020；Alonso Pacheco等人，2019）。治疗T型子宫的经典手术技术是用微型剪刀或双极针进行侧壁切开，形成三角形的子宫腔。在这篇视频文章中，我们描述了一种新的手术技术，该技术是在办公室环境中结合三维超声（3D-US）和宫腔镜子宫成形术，使用15Fr办公室切除镜（Karl Storz，Tuttlingen，Germany），通过切除子宫壁的侧纤维肌组织来治疗T形子宫。无并发症发生，术后宫腔镜检查显示宫腔呈三角形对称，无任何粘连。

{"title":"New approach for T-shaped uterus: Metroplasty with resection of lateral fibromuscular tissue using a 15 Fr miniresectoscope. A step-by-step technique.","authors":"U. Catena, R. Campo, G. Bolomini, M. Moruzzi, V. Verdecchia, F. Nardelli, I. Romito, F. Camolo, V. L. Manna, M. Ianieri, G. Scambia, A. Testa","doi":"10.52054/FVVO.13.003","DOIUrl":"https://doi.org/10.52054/FVVO.13.003","url":null,"abstract":"T-shaped uterus is a congenital uterine malformation (CUM), only recently defined by the ESGE ESHRE classification as Class U1a. The uterus is characterised by a narrow uterine cavity due to thickened lateral walls with a correlation 2/3 uterine corpus and 1/3 cervix (Grimbizis et al, 2013). Although the significance of this dysmorphic malformation on reproductive performance has been questioned, recent studies reported significant improvement of life birth rates after surgical correction in patients with failed in-vitro fertilisation (IVF) or recurrent miscarriage (Ferro et al, 2018; Di Spiezio Sardo et al, 2020; Alonso Pacheco et al. 2019). The classical surgical technique to treat a T-shaped uterus is by performing a sidewall incision with the micro scissor or bipolar needle, resulting in a triangular cavity. \u0000In this video article, we describe a new surgical technique with a step-by-step method combining three-dimensional ultrasound (3D-US) and hysteroscopic metroplasty in an office setting, using a 15 Fr office resectoscope (Karl Storz, Tuttlingen, Germany), to treat a T-shaped uterus by resecting the lateral fibromuscular tissue of the uterine walls. No complications occurred and the postoperative hysteroscopy showed a triangular and symmetrical uterine cavity without any adhesions.","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":"13 1","pages":"67-71"},"PeriodicalIF":2.0,"publicationDate":"2021-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45831314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Treatment of ovarian endometriomas using plasma energy in endometriosis surgery: effect on pelvic pain, return to work, pregnancy and cyst recurrence. 在子宫内膜异位症手术中使用等离子能量治疗卵巢子宫内膜异位症：对盆腔疼痛、重返工作岗位、怀孕和囊肿复发的影响。

IF 1.7 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2019-03-01

E K Lockyer, Amf Schreurs, McI Lier, Jjml Dekker, I Melgers, V Mijatovic

Background: The best surgical technique for managing ovarian endometriomas is still widely debated, though the current standard is stripping cystectomy. The use of plasma energy as a treatment option is a relatively new concept and little data is currently available on this method. The aim of this study was to determine the feasibility of the use of plasma energy in our daily clinical practice by looking at various postoperative outcomes.

Methods: Twenty-one women previously diagnosed with uni- or bilateral ovarian endometriomas by transvaginal ultrasound, associated with pelvic pain and/or infertility, were included in this retrospective cohort study performed in a tertiary endometriosis referral centre. All women underwent endometriotic cyst ablation using plasma energy. At follow up postoperative pain, number of days until return to work following surgery, postoperative pregnancy rate and recurrence rate were determined.

Results: This study demonstrates a significant decrease in the proportion of patients reporting pain postoperatively when comparing the number of patients with dysmenorrhoea, dyspareunia, and chronic pelvic pain pre- and postoperatively. In addition, the median number of days until women returned to work postoperatively was 9 days (interquartile range (IQR) 8-11 days). The postoperative pregnancy rate was 46.2% (6 of 13 women wishing to conceive) and the recurrence rate was 9.5%.

Conclusions: In conclusion, plasma energy is a promising alternative to stripping cystectomy, as comparable results for postoperative pregnancy and recurrence rates can be observed. However, further research is necessary to draw firm conclusions when comparing these two techniques.

背景：治疗卵巢子宫内膜异位症的最佳手术技术仍存在广泛争议，尽管目前的标准是剥除膀胱切除术。使用等离子体能作为一种治疗方法是一个相对较新的概念，目前有关这种方法的数据很少。本研究旨在通过观察各种术后结果，确定在日常临床实践中使用等离子能量的可行性：这项回顾性队列研究纳入了 21 名曾被经阴道超声诊断为单侧或双侧卵巢子宫内膜异位症、伴有盆腔疼痛和/或不孕的女性，研究在一家三级子宫内膜异位症转诊中心进行。所有妇女都接受了等离子能量子宫内膜异位囊肿消融术。在随访中确定了术后疼痛、术后恢复工作的天数、术后怀孕率和复发率：结果：这项研究表明，比较术前和术后痛经、排便困难和慢性盆腔疼痛的患者人数，术后报告疼痛的患者比例明显下降。此外，妇女术后重返工作岗位的中位天数为 9 天（四分位距（IQR）为 8-11 天）。术后怀孕率为46.2%（13名希望怀孕的女性中有6名），复发率为9.5%：总之，等离子能量术是一种很有前途的膀胱剥脱术替代方法，因为术后妊娠率和复发率的结果相当。不过，要对这两种技术进行比较并得出确切结论，还需要进一步的研究。

{"title":"Treatment of ovarian endometriomas using plasma energy in endometriosis surgery: effect on pelvic pain, return to work, pregnancy and cyst recurrence.","authors":"E K Lockyer, Amf Schreurs, McI Lier, Jjml Dekker, I Melgers, V Mijatovic","doi":"","DOIUrl":"","url":null,"abstract":"Background: The best surgical technique for managing ovarian endometriomas is still widely debated, though the current standard is stripping cystectomy. The use of plasma energy as a treatment option is a relatively new concept and little data is currently available on this method. The aim of this study was to determine the feasibility of the use of plasma energy in our daily clinical practice by looking at various postoperative outcomes.Methods: Twenty-one women previously diagnosed with uni- or bilateral ovarian endometriomas by transvaginal ultrasound, associated with pelvic pain and/or infertility, were included in this retrospective cohort study performed in a tertiary endometriosis referral centre. All women underwent endometriotic cyst ablation using plasma energy. At follow up postoperative pain, number of days until return to work following surgery, postoperative pregnancy rate and recurrence rate were determined.Results: This study demonstrates a significant decrease in the proportion of patients reporting pain postoperatively when comparing the number of patients with dysmenorrhoea, dyspareunia, and chronic pelvic pain pre- and postoperatively. In addition, the median number of days until women returned to work postoperatively was 9 days (interquartile range (IQR) 8-11 days). The postoperative pregnancy rate was 46.2% (6 of 13 women wishing to conceive) and the recurrence rate was 9.5%.Conclusions: In conclusion, plasma energy is a promising alternative to stripping cystectomy, as comparable results for postoperative pregnancy and recurrence rates can be observed. However, further research is necessary to draw firm conclusions when comparing these two techniques.","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":"11 1","pages":"49-55"},"PeriodicalIF":1.7,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141731498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

OC22.01: Who is at risk of endometrial cavity breach at laparoscopic myomectomy? OC22.01:腹腔镜子宫肌瘤切除术中哪些人有子宫内膜腔破裂的风险?

IF 2 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2018-10-01 DOI: 10.1002/uog.19354

K. Rajah, K. Kriedt, N. Balachandren, M. Moghazy, E. Burt, D. Mavrelos

(>3) sonographic findings, respectively. PPV of major or multiple minor US abnormalities in case of symptomatic congenital infection were 80,0 % in fetuses or infants with congenital infection, and 61.5% when all exposed fetuses were considered, with a specificity of 95.7% and 98.1%, respectively. Conclusions: When fetal status is unknown, any US abnormality can only predict a symptomatic congenital infection in 41.3% of cases. The classification of US semiology as major and minor infectious criteria leads to increase US prediction performance of symptomatic congenital infection when major or multiple minor criteria are found.

(bbbb3)超声检查结果。有症状的先天性感染时，主要或多重轻微US异常的PPV在有先天性感染的胎儿或婴儿中分别为80%、0%，在考虑所有暴露胎儿时为61.5%，特异性分别为95.7%和98.1%。结论:当胎儿状态未知时，任何US异常只能预测41.3%的有症状的先天性感染。将US符号学分为主要和次要感染标准，当发现主要或多个次要标准时，可以提高US对有症状的先天性感染的预测性能。

引用次数: 3

Intra-peritoneal leiomyoma of the round ligament in a patient with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome 一例mayer - rokitansky - k<s:1> ster- hauser (MRKH)综合征患者的圆形韧带腹膜内平滑肌瘤

IF 2 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2016-12-01 DOI: 10.21767/2471-8165.1000038

G. S. Wehbe, R. Bitar, T. Zreik, Michel Samaha, C. Walter, Z. Sleiman

Abstract Background The occurrence of an extra-uterine leiomyoma, arising from the intra-peritoneal portion of the round ligament in a lady with Müllerian agenesis diagnosed at the age of forty is extremely rare. We report a case of this rare combination in a Middle Eastern woman. Case A 40 years old lady, primarily amenorrheic, presented to our clinic for an infertility consultation. The work- up showed features suggestive of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome with a leiomyoma arising from the intra-peritoneal part of the round ligament.

摘要背景子宫外平滑肌瘤的发生，起源于圆形韧带腹膜内的一部分，在40岁诊断为勒氏体发育不全的女性是非常罕见的。我们报告一例这种罕见的组合在一个中东妇女。病例一名40岁的女性，主要是闭经，到我们诊所进行不孕不育咨询。工作显示的特征提示迈尔-罗基塔斯基- k斯特-豪瑟(MRKH)综合征，平滑肌瘤起源于圆形韧带腹膜内部分。

引用次数: 7

Intra-peritoneal leiomyoma of the round ligament in a patient with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. 一名梅尔-罗基坦斯基-库斯特-豪泽尔（MRKH）综合征患者的腹膜内圆韧带子宫肌瘤。

IF 2 Q3 OBSTETRICS & GYNECOLOGY

Facts Views and Vision in ObGyn

Pub Date : 2016-12-01

G Salem Wehbe, R Bitar, T Zreik, M Samaha, C Walter, Z Sleiman

Background: The occurrence of an extra-uterine leiomyoma, arising from the intra-peritoneal portion of the round ligament in a lady with Müllerian agenesis diagnosed at the age of forty is extremely rare. We report a case of this rare combination in a Middle Eastern woman.

Case: A 40 years old lady, primarily amenorrheic, presented to our clinic for an infertility consultation. The work- up showed features suggestive of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome with a leiomyoma arising from the intra-peritoneal part of the round ligament.

背景：40 岁时被诊断为穆勒氏子宫发育不良的女性中，出现了来自圆韧带腹膜内部分的子宫外子宫肌瘤，这种情况极为罕见。我们报告了一例中东女性的罕见合并症：病例：一位 40 岁的妇女，主要是闭经，来我院咨询不孕症。检查结果显示，她患有梅尔-罗基坦斯基-库斯特-豪泽（MRKH）综合征，腹膜内圆韧带处长有一个子宫肌瘤。

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Facts Views and Vision in ObGyn

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀